For nearly 40 years, Children's Mercy has been a leader in neonatal research, with focused expertise in chronic lung disease. As a pioneer in nitric oxide therapy, we're investigating advanced treatments in our new Center for Infant Pulmonary Disorders.
Current Research Areas
Clinical research within the Division of Neonatology is focused on lung development, nutrition, pharmacokinetics, genomics, and long-term outcomes.
In collaboration with the Divisions of Cardiology and Pulmonology, Division Director Howard Kilbride, MD, is investigating whether these children continue to be at elevated risk for impaired cardiopulmonary function and exercise-related problems as they get older. Through collaboration with clinical coordinators, quality improvement coordinators and data managers, the division promotes research that will improve care and outcomes for infants admitted to the NICU.
Children’s Mercy neonatologists are working with the Center for Pediatric Genomic Medicine to quickly diagnose children with complex medical conditions and move them into appropriate treatment.
Learn more »
Donald W. Thibeault Neonatal Research Laboratory
The Donald W. Thibeault Neonatal Research Laboratory focuses on developmental lung biology and uses lung cell culture and animal models to understand how oxygen supplementation and oxidative stress cause pulmonary cell death, neonatal lung injury and bronchopulmonary dysplasia (BPD).